ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
James V. O'Connor
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Connor, J. V.
Right arrow Articles by Scalea, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Connor, J. V.
Right arrow Articles by Scalea, T. M.
Related Collections
Right arrow Lung - other

Ann Thorac Surg 2006;81:1485-1487
© 2006 The Society of Thoracic Surgeons

Case report

Traumatic Hemoptysis Treated With Recombinant Human Factor VIIa

James V. O'Connor, MD a , * , Deborah M. Stein, MD b , Richard P. Dutton, MD c , Thomas M. Scalea, MD d

a Department of Thoracic and Vascular Surgery, R. Adams Cowley Shock Trauma Center, Baltimore, Maryland
b Department of Trauma and Critical Care, R. Adams Cowley Shock Trauma Center, Baltimore, Maryland
c Department of Anesthesiology, R. Adams Cowley Shock Trauma Center, Baltimore, Maryland
d Program in Trauma Department, R Adams Cowley Shock Trauma Center, Baltimore, Maryland

Accepted for publication March 8, 2005.

* Address correspondence to Dr O'Connor, Thoracic and Vascular Surgery, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, 22 S Greene St, Baltimore, MD 21201 (Email: joconnor{at}umm.edu).

Blunt thoracic trauma resulting in massive hemoptysis is rare. Although there are several indications for the administration of recombinant factor VIIa, we are unaware of a report of its utilization in the treatment of hemoptysis following chest trauma. We report a case of the successful use of factor VIIa in the treatment of life-threatening hemoptysis secondary to blunt force thoracic injury and traumatic coagulopathy.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
H. C.N. Tien, M. R.C. Gough, R. Farrell, and J. Macdonald
Successful Use of Recombinant Activated Coagulation Factor VII in a Patient with Massive Hemoptysis From a Penetrating Thoracic Injury
Ann. Thorac. Surg., October 1, 2007; 84(4): 1373 - 1374.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.